ANGO Financial Facts

Income before income tax provision: 1.42M
Interest expense: -799K
See Full Income Statement

Cash and cash equivalents: 13.81M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 796.11M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 1/9/15 *Est. EPS Growth Rate +300.0% *Last Qtr.
Average EPS % Beat Rate +68.3% Revenue Growth Rate +4.4% *Last Qtr.
Average % Move 1-Wk after EPS -1.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/9/14 Q115 $0.16$0.11 +$0.05$87.3M$85.3M Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M Details
4/9/14 Q314 $0.16$0.09 +$0.07$88.2M$86.85M N/A Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A Details
10/10/13 Q114 $0.04$0.03 +$0.01$83.6M$82.54M Details
7/11/13 Q413 $0.07$0.06 +$0.01$90M$86.43M N/A Details
4/4/12 Q313 $0.09$0.08 +$0.01$51.6M$51.34M = Details
4/8/13 Q313 $0.05$0.05 $0.00$81.6M$81.7M = Details